LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 99

Search options

  1. Article ; Online: Motor symptoms of Parkinson's disease are affected by temperature: A controlled pilot study.

    Huang, Ting / Wang, Xi-Xi / Gao, Chen-Yu / Zhao, Jin-Ying / Pan, Rong-Rong / Jin, Hui-Hui / Tian, You-Yong / Zhang, Ying-Dong

    Brain and behavior

    2024  Volume 14, Issue 1, Page(s) e3369

    Abstract: Purpose: The motor symptoms (MS) of Parkinson's disease (PD) have been affecting the quality of life in patients. In clinical practice, most patients with PD report that MS are more severe in winter than in summer, and hyperthermic baths (HTB) could ... ...

    Abstract Purpose: The motor symptoms (MS) of Parkinson's disease (PD) have been affecting the quality of life in patients. In clinical practice, most patients with PD report that MS are more severe in winter than in summer, and hyperthermic baths (HTB) could temporarily improve MS. The study aimed to evaluate the effects of seasonal variation and aquatic thermal environment of HTB on the MS of PD.
    Patients and methods: A cross-sectional study of 203 Chinese Han patients was performed. Univariate and multivariate analyses were performed to analyze seasonal variation in MS relative to baseline data (sex, age at onset, duration, season of birth, Hoehn and Yahr stage, family history, levodopa equivalent dose, and the effect of HTB on MS). Ten subjects participated in the HTB study, and one patient dropped out. The paired Wilcoxon rank test was used to assess the differences in the Movement Disorder Society-United Parkinson's disease Rating Scale (MDS-UPDRS) part III motor examination total scores and the modified Webster Symptoms Score between non-HTB and before HTB and between non-HTB and after HTB.
    Results: The improvement of MS after HTB was an independent risk factor for seasonal variation in MS (OR, 25.203; 95% CI, 10.951-58.006; p = .000). Patients with PD had significant improvements in the MDS-UPDRS part III motor examination total scores, especially in bradykinesia (p = .043), rigidity (p = .008), posture (p = .038), and rest tremor amplitude (p = .047).
    Conclusion: Seasonal variation in temperature and water temperature of HTB may affect MS in some patients with PD. Simple HTB could be recommended as physiotherapy for patients with PD who report temperature-sensitive MS.
    MeSH term(s) Humans ; Cross-Sectional Studies ; Parkinson Disease/drug therapy ; Pilot Projects ; Quality of Life ; Salicylates ; Temperature
    Chemical Substances 4-trifluoromethylsalicylic acid (328-90-5) ; Salicylates
    Language English
    Publishing date 2024-02-20
    Publishing country United States
    Document type Controlled Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2623587-0
    ISSN 2162-3279 ; 2162-3279
    ISSN (online) 2162-3279
    ISSN 2162-3279
    DOI 10.1002/brb3.3369
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: The

    Fu, Xin-Xin / Chen, Shuai-Yu / Lian, Hui-Wen / Deng, Yang / Duan, Rui / Zhang, Ying-Dong / Jiang, Teng

    Brain sciences

    2023  Volume 13, Issue 4

    Abstract: Previously, we reported that H157Y, a rare coding variant on exon 3 of the triggering receptor expressed on myeloid cells 2 gene ( ...

    Abstract Previously, we reported that H157Y, a rare coding variant on exon 3 of the triggering receptor expressed on myeloid cells 2 gene (
    Language English
    Publishing date 2023-04-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci13040642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Drooling disrupts the brain functional connectivity network in Parkinson's disease.

    Huang, Ting / Tang, Li-Li / Zhao, Jin-Ying / Shang, Song An / Chen, Yu-Chen / Tian, You-Yong / Zhang, Ying-Dong

    CNS neuroscience & therapeutics

    2023  Volume 29, Issue 10, Page(s) 3094–3107

    Abstract: Aims: This study aimed to investigate the causal interaction between significant sensorimotor network (SMN) regions and other brain regions in Parkinson's disease patients with drooling (droolers).: Methods: Twenty-one droolers, 22 PD patients ... ...

    Abstract Aims: This study aimed to investigate the causal interaction between significant sensorimotor network (SMN) regions and other brain regions in Parkinson's disease patients with drooling (droolers).
    Methods: Twenty-one droolers, 22 PD patients without drooling (non-droolers), and 22 matched healthy controls underwent 3T-MRI resting-state scans. We performed independent component analysis and Granger causality analysis to determine whether significant SMN regions help predict other brain areas. Pearson's correlation was computed between imaging characteristics and clinical characteristics. ROC curves were plotted to assess the diagnostic performance of effective connectivity (EC).
    Results: Compared with non-droolers and healthy controls, droolers showed abnormal EC of the right caudate nucleus (CAU.R) and right postcentral gyrus to extensive brain regions. In droolers, increased EC from the CAU.R to the right middle temporal gyrus was positively correlated with MDS-UPDRS, MDS-UPDRS II, NMSS, and HAMD scores; increased EC from the right inferior parietal lobe to CAU.R was positively correlated with MDS-UPDRS score. ROC curve analysis showed that these abnormal ECs are of great significance in diagnosing drooling in PD.
    Conclusion: This study identified that PD patients with drooling have abnormal EC in the cortico-limbic-striatal-cerebellar and cortio-cortical networks, which could be potential biomarkers for drooling in PD.
    MeSH term(s) Humans ; Sialorrhea/diagnostic imaging ; Sialorrhea/etiology ; Parkinson Disease/complications ; Parkinson Disease/diagnostic imaging ; Brain/diagnostic imaging ; Parietal Lobe ; Magnetic Resonance Imaging
    Language English
    Publishing date 2023-05-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2423461-8
    ISSN 1755-5949 ; 1755-5930
    ISSN (online) 1755-5949
    ISSN 1755-5930
    DOI 10.1111/cns.14251
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.

    Fu, Xin-Xin / Wei, Bin / Cao, Hai-Ming / Duan, Rui / Deng, Yang / Lian, Hui-Wen / Zhang, Ying-Dong / Jiang, Teng

    Journal of Alzheimer's disease : JAD

    2023  Volume 94, Issue 3, Page(s) 919–933

    Abstract: Background: Alzheimer's disease (AD) is the most common type of neurodegenerative disorder. There are few effective medications for halting the progression of AD. Telmisartan (TEL) is a widely used anti-hypertensive drug approved by FDA. Aside from ... ...

    Abstract Background: Alzheimer's disease (AD) is the most common type of neurodegenerative disorder. There are few effective medications for halting the progression of AD. Telmisartan (TEL) is a widely used anti-hypertensive drug approved by FDA. Aside from treating hypertension, TEL has been revealed to provide protection against AD. However, the underlying mechanisms remain unclear.
    Objective: To investigate the mechanisms underlying the beneficial effects of TEL against AD.
    Methods: Eight-month-old APP/PS1 mice were administered with 5 mg/kg TEL once per day for 4 successive months. Nesting test, Y-maze test, and Morris water maze test were employed to assess the cognitive and executive functions. Neuronal and synaptic markers, amyloid-β (Aβ) pathology, neuroinflammation, and oxidative stress in the brains were measured. Specifically, components involved in Aβ production and degradation pathway were analyzed to explore the mechanisms underlying the therapeutic effect of TEL against Aβ pathology. The primary microglia were used to uncover the mechanisms underlying the anti-inflammatory effects of TEL in AD. Additionally, the preventive effect of TEL against AD were investigated using 4-month-old APP/PS1 mice.
    Results: TEL treatment ameliorated cognitive and executive impairments, neuronal and synaptic injury, Aβ pathology, neuroinflammation, and oxidative stress in APP/PS1 mice. The favorable effects of TEL on Aβ pathology were achieved by inhibiting enzymatic Aβ production and facilitating enzymatic and autophagic Aβ degradation. Meanwhile, the anti-inflammatory effects of TEL were accomplished via microglial PPARγ/NLRP3 pathway. The administration of TEL prior to symptom onset prevented AD-related cognitive decline and neuropathologies.
    Conclusion: TEL represents a promising agent for AD prevention and treatment.
    MeSH term(s) Mice ; Animals ; Alzheimer Disease/complications ; Alzheimer Disease/drug therapy ; Alzheimer Disease/metabolism ; Telmisartan/therapeutic use ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Mice, Transgenic ; Neuroinflammatory Diseases ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/etiology ; Cognitive Dysfunction/metabolism ; Amyloid beta-Peptides/metabolism ; Anti-Inflammatory Agents/therapeutic use ; Disease Models, Animal
    Chemical Substances Telmisartan (U5SYW473RQ) ; Amyloid beta-Protein Precursor ; Amyloid beta-Peptides ; Anti-Inflammatory Agents
    Language English
    Publishing date 2023-06-17
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230133
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Pretreatment with simvastatin upregulates expression of BK-2R and CD11b in the ischemic penumbra of rats.

    Zhang, Jian-Ying / Bai, Qing-Ke / Zhang, Ying-Dong

    Journal of biomedical research

    2018  Volume 32, Issue 5, Page(s) 354–360

    Abstract: Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductases, collectively known as statins, have been shown to minimize cerebral ischemic events in patients. We assessed the mechanisms of simvastatin pretreatment in preventing cerebral ischemia/ ... ...

    Abstract Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductases, collectively known as statins, have been shown to minimize cerebral ischemic events in patients. We assessed the mechanisms of simvastatin pretreatment in preventing cerebral ischemia/reperfusion injury in rats using a model of middle cerebral artery occlusion (MCAO). Rats were pretreated with simvastatin 14 days prior to MCAO induction. At 3, 24, and 48 hours after reperfusion, bradykinin levels in the ischemic penumbra were assayed by ELISA, mRNA levels of bradykinin B2 receptors (BK-2Rs) and CD11b were measured by fluorescent quantitative real-time PCR (RT-PCR), and co-expression of microglia and BK-2Rs was determined by immunofluorescence. Simvastatin had no effect on bradykinin expression in the ischemic penumbra at any time point. However, the levels of BK-2R and CD11b mRNA in the ischemic penumbra, which were significantly decreased 3 hours after ischemia-reperfusion, were increased in simvastatin-pretreated rats. Moreover, the co-expression of BK-2Rs and microglia was confirmed by immunofluorescence analysis. These results suggest that the beneficial effects of simvastatin pretreatment before cerebral ischemia/reperfusion injury in rats may be partially due to increased expression of BK-2R and CD11b in the ischemic penumbra.
    Language English
    Publishing date 2018-05-23
    Publishing country China
    Document type Journal Article
    ZDB-ID 2555537-6
    ISSN 1876-4819 ; 1674-8301
    ISSN (online) 1876-4819
    ISSN 1674-8301
    DOI 10.7555/JBR.32.20160152
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Reduced gray matter volume in male adolescent violent offenders.

    Zhang, Ying-Dong / Zhou, Jian-Song / Lu, Feng-Mei / Wang, Xiao-Ping

    PeerJ

    2019  Volume 7, Page(s) e7349

    Abstract: Background: Previous studies reported that reduced gray matter volume (GMV) was associated with violent-related behaviors. However, the previous studies were conducted on adults and no study has studied the association between GMV and violent behaviors ... ...

    Abstract Background: Previous studies reported that reduced gray matter volume (GMV) was associated with violent-related behaviors. However, the previous studies were conducted on adults and no study has studied the association between GMV and violent behaviors on adolescents. The purpose of the study was to investigate GMV's effects in adolescent violent offenders based on a Chinese Han population, which can address the problem of possible confounding factors in adult studies.
    Methods: We recruited 30 male adolescent violent offenders and 29 age- and sex-matched healthy controls (HCs). Differences in both whole-brain and GMV were evaluated using voxel-based morphometry (VBM). We assessed the accuracy of VBM using the receiver operating characteristic curve (ROC) and discriminant analysis.
    Results: Compared with HCs, the male adolescent offenders showed significantly reduced GMV in five cortical and subcortical brain regions, including the olfactory cortex, amygdala, middle temporal gyrus and inferior parietal lobe in the left hemisphere, as well as the right superior temporal gyrus. Both ROC curve and discriminate analyses showed that these regions had relatively high sensitivities (58.6%-89.7%) and specificities (58.1%-74.2%) with 76.7% classification accuracy.
    Conclusions: Our results indicated that reduced volume in the frontal-temporal-parietal-subcortical circuit may be closely related to violent behaviors in male adolescents, which might be an important biomarker for detecting violent behaviors in male adolescents.
    Language English
    Publishing date 2019-09-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2703241-3
    ISSN 2167-8359
    ISSN 2167-8359
    DOI 10.7717/peerj.7349
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Role of TREML2 in Alzheimer's Disease.

    Wang, Si-Yu / Gong, Peng-Yu / E, Yan / Zhang, Ying-Dong / Jiang, Teng

    Journal of Alzheimer's disease : JAD

    2020  Volume 76, Issue 3, Page(s) 799–806

    Abstract: Late-onset Alzheimer's disease (AD) accounts for most of all AD casesand is currently considered a complex disorder caused by a combination of environmental and genetic factors. As an important family member of triggering receptor expressed on myeloid ... ...

    Abstract Late-onset Alzheimer's disease (AD) accounts for most of all AD casesand is currently considered a complex disorder caused by a combination of environmental and genetic factors. As an important family member of triggering receptor expressed on myeloid cells (TREM), TREM-like transcript 2 gene (TREML2) locates on human chromosome 6p21.1, a newly-identified hot zone for AD susceptibility, and encodes atransmembrane immune receptor. Emerging evidence implied a potential role of TREML2 in the susceptibility and pathogenesis of AD. Here, we review the recent literature about the association of TREML2 variants with AD risk and disease endophenotypes. Moreover, we summarize the latest findings regarding cellular localization and biological functions of TREML2 and speculate its possible role in AD pathogenesis. In addition, we discuss future research directions of TREML2 and AD.
    MeSH term(s) Alzheimer Disease/genetics ; Alzheimer Disease/pathology ; Endophenotypes/metabolism ; Humans ; Membrane Glycoproteins/genetics ; Microglia/metabolism ; Microglia/pathology ; Receptors, Immunologic/genetics ; Receptors, Immunologic/metabolism
    Chemical Substances Membrane Glycoproteins ; Receptors, Immunologic ; TREML2 protein, human
    Language English
    Publishing date 2020-06-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-200406
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease.

    Shi, Jian-Quan / Wang, Bian-Rong / Jiang, Teng / Gao, Li / Zhang, Ying-Dong / Xu, Jun

    Journal of Alzheimer's disease : JAD

    2020  Volume 77, Issue 3, Page(s) 923–934

    Abstract: As one of the most harmful air pollutants, fine particulate matter (PM2.5) has been implicated as a risk factor for multiple diseases, which has generated widespread public concern. Accordingly, a growing literature links PM2.5 exposure with Alzheimer's ... ...

    Abstract As one of the most harmful air pollutants, fine particulate matter (PM2.5) has been implicated as a risk factor for multiple diseases, which has generated widespread public concern. Accordingly, a growing literature links PM2.5 exposure with Alzheimer's disease (AD). A critical gap in our understanding of the adverse effects of PM2.5 on AD is the mechanism triggered by PM2.5 that contributes to disease progression. Recent evidence has demonstrated that PM2.5 can activate NLRP3 inflammasome-mediated neuroinflammation. In this review, we highlight the novel evidence between PM2.5 exposure and AD incidence, which is collected and summarized from neuropathological, epidemiological, and neuroimaging studies to in-depth deciphering molecular mechanisms. First, neuropathological, epidemiological, and neuroimaging studies will be summarized. Then, the transport pathway for central nervous system delivery of PM2.5 will be presented. Finally, the role of NLRP3 inflammasome-mediated neuroinflammation in PM2.5 induced-effects on AD will be recapitulated.
    MeSH term(s) Air Pollutants/adverse effects ; Alzheimer Disease/chemically induced ; Alzheimer Disease/drug therapy ; Alzheimer Disease/metabolism ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/metabolism ; Drug Delivery Systems/methods ; Humans ; NLR Family, Pyrin Domain-Containing 3 Protein/antagonists & inhibitors ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Particulate Matter/adverse effects
    Chemical Substances Air Pollutants ; Anti-Inflammatory Agents ; NLR Family, Pyrin Domain-Containing 3 Protein ; NLRP3 protein, human ; Particulate Matter
    Language English
    Publishing date 2020-08-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-200359
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer's Disease by Enhancing Autophagy.

    Deng, Yang / Wang, Si-Yu / Wang, Qing-Guang / Xu, Zhao-Han / Peng, Qiang / Chen, Shuai-Yu / Zhu, Lin / Zhang, Ying-Dong / Duan, Rui

    Journal of inflammation research

    2023  Volume 16, Page(s) 391–406

    Abstract: Purpose: Our previous study has shown that AVE 0991, a nonpeptide analogue of Ang-(1-7), ameliorates cognitive decline and inhibits NLRP3 inflammasome of astrocytes in Alzheimer's disease model mice. Additionally, several studies have suggested that ... ...

    Abstract Purpose: Our previous study has shown that AVE 0991, a nonpeptide analogue of Ang-(1-7), ameliorates cognitive decline and inhibits NLRP3 inflammasome of astrocytes in Alzheimer's disease model mice. Additionally, several studies have suggested that activation of autophagy appears to effectively inhibit the progression of neuroinflammation. However, it is unclear whether AVE 0991 can modulate astrocyte autophagy to suppress neuroinflammation in Alzheimer's disease.
    Materials and methods: APP/PS1 mice and Aβ-treated primary astrocytes were used as the research objects in vivo and in vitro, respectively. Water maze test was used to evaluate cognitive function of mice, Nissl staining and immunofluorescence staining was used to assess neuronal damage. ELISA kits were used to detect the levels of Ang-(1-7) and Aβ in the cortex, and qRT-PCR was used to detect the expression of cortical inflammation-related mediators. The expression of autophagy-related proteins in cortex were detected by Western blot. The upstream molecular responses involved in inflammation inhibition by AVE 0991 were validated by means of using the Mas1 antagonist and autophagy inhibitor.
    Results: We found that 30 days of intraperitoneal administration of AVE 0991 improved. Aβ deposition, neuronal death, and cognitive deficits in APP/PS1 Alzheimer's disease model mice. Moreover, AVE 0991 treatment greatly suppressed astrocyte-mediated inflammation and up-regulated the expression of autophagy. Furthermore, the inhibitory effect of AVE 0991 on the expression of inflammatory factors was reversed by 3-MA, an autophagy inhibitor.
    Conclusion: These findings suggest that regulation of autophagy is critical for inhibiting astrocyte neuroinflammatory responses and demonstrate a potential neuroprotective mechanism by which AVE 0991 could suppress neuroinflammatory responses by enhancing autophagy.
    Language English
    Publishing date 2023-02-01
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2494878-0
    ISSN 1178-7031
    ISSN 1178-7031
    DOI 10.2147/JIR.S392599
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Identification of new bisabosqual-type meroterpenoids reveals non-enzymatic conversion of bisabosquals into

    Tong, Meng-Xi / Duan, Yong-Xia / Zhang, Ying-Dong / Ye, Wan-Yi / Qin, Sheng-Ying / Liu, Xing-Zhong / Chen, Guo-Dong / Lv, Jian-Ming / Hu, Dan / Gao, Hao

    Organic & biomolecular chemistry

    2023  Volume 21, Issue 35, Page(s) 7141–7150

    Abstract: Bisabosqual-type meroterpenoids are fungi-derived polyketide-terpenoid hybrids bearing a 2,3,3a, ... ...

    Abstract Bisabosqual-type meroterpenoids are fungi-derived polyketide-terpenoid hybrids bearing a 2,3,3a,3a
    MeSH term(s) Benzopyrans ; Polyketides ; Radiopharmaceuticals ; Terpenes
    Chemical Substances Benzopyrans ; Polyketides ; Radiopharmaceuticals ; Terpenes
    Language English
    Publishing date 2023-09-13
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2097583-1
    ISSN 1477-0539 ; 1477-0520
    ISSN (online) 1477-0539
    ISSN 1477-0520
    DOI 10.1039/d3ob01110k
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top